ERBB2 and breast cancer: Studies conducted across populations and specialized centers consistently demonstrate that women in Latin America face a 20–40% greater likelihood of developing specific subtypes of breast cancer, including ER−/PR−/HER2+ and triple-negative breast cancer (TNBC), when compared to Non-Hispanic White (NHW) women [32].